CLOSE X
GO

Tata India Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
29.56 -0.16(-0.53%) NAV as on 09 Mar 2026
0.96 % 1 M
7.31 % 1 Y
23.61 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.14

As on 31 Jan, 2026
age-icon Age :

10 yrs 2 m

Since 28 12 ,2015
exit_load Exit Load :

0.25%

aum AUM :

1,300.81 Crs

lock_in Lock-in :

0.25% on or before 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

8.31

Min_Investment Min. Investment :

SIP 100 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

NA

Fund_manager Fund Manager :

Rajat Srivastava

LATEST ASSET & PORTFOLIO ALLOCATION

as on Feb 28 ,2026
Others 2.41 %
Equity 97.59 %

TOP HOLDINGS

Sun Pharmaceutical Industries...9.66 %
Max Healthcare Institute Ltd.6.78 %
Divi's Laboratories Ltd.5.94 %
Abbott India Ltd.5.60 %
Healthcare Global Enterprises...5.04 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs56.31
Hospital & Healthcare Services35.54
Pesticides & Agrochemicals3.33
Business Support2.39
Medical Equipment/Supplies/Accessories0.02
See All Sectors

5-YEARS HISTORY

Financial Year2021-20222022-20232023-20242024-20252025-2026
NAV in Rs (as on 09-Mar-2026)17.1815.8825.0628.6429.56
Net Assets(Rs Crores) (as on 09-Mar-2026) 553.33 493.44 878.70 1183.65 1300.81
Scheme Returns(%)(Absolute)16.04-7.3157.4613.014.35
B'mark Returns(%)(Absolute)NANANANANA
Category Rank41/7567/7619/9020/10254/118

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity29.56-0.16(-0.53%)NAV As on 09 Mar, 202628-Dec-2015Inception Date1,300.81AUM In Cr.7.31%1Y23.61%3Y15.25%5Y11.21%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity37.79-0.17(-0.45%)NAV As on 09 Mar, 202613-Jul-2018Inception Date6,801.16AUM In Cr.7.42%1Y27.18%3Y16.78%5Y18.95%Since Inception
Mirae Asset Healthcare Fund-Reg(G)Very HighEquity38.94-0.14(-0.36%)NAV As on 09 Mar, 202602-Jul-2018Inception Date2,639.92AUM In Cr.12.55%1Y25.03%3Y15.96%5Y19.33%Since Inception
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity31.010.03(0.10%)NAV As on 09 Mar, 202610-Jul-2019Inception Date854.04AUM In Cr.9.77%1Y24.01%3Y14.33%5Y18.50%Since Inception
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors